BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 15467023)

  • 1. Despite positive studies, popularity of chemoprevention drugs increasing slowly.
    Zielinski SL
    J Natl Cancer Inst; 2004 Oct; 96(19):1410-2. PubMed ID: 15467023
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical trials referral resource. Breast cancer and prostate cancer.
    Brawley OW; Cheson BD; Phillips PH
    Oncology (Williston Park); 1996 Jan; 10(1):100, 102. PubMed ID: 8924360
    [No Abstract]   [Full Text] [Related]  

  • 3. Non-steroidal anti-inflammatory drugs in chemoprevention of breast and prostate cancer.
    Badawi AF; El-Sohemy A
    Med Hypotheses; 2001 Aug; 57(2):167-8. PubMed ID: 11461166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemoprevention: drug pricing and mortality: the case of tamoxifen.
    Melnikow J; Kuenneth C; Helms LJ; Barnato A; Kuppermann M; Birch S; Nuovo J
    Cancer; 2006 Sep; 107(5):950-8. PubMed ID: 16865680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aspirin may protect against breast cancer. But tamoxifen and mastectomy are still the only proven preventatives, though other approaches are under study.
    Health News; 2004 Sep; 10(9):6. PubMed ID: 15597442
    [No Abstract]   [Full Text] [Related]  

  • 6. Re: Effect of nonsteroidal anti-inflammatory agents and finasteride on prostate cancer risk.
    Pruthi RS; Derksen JE; Gaston K
    J Urol; 2003 Jun; 169(6):2304; author reply 2304-5. PubMed ID: 12771783
    [No Abstract]   [Full Text] [Related]  

  • 7. Tamoxifen or raloxifene for breast cancer chemoprevention: a tale of two choices--point.
    Jordan VC
    Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2207-9. PubMed ID: 18006908
    [No Abstract]   [Full Text] [Related]  

  • 8. Researchers plan to continue to study COX-2 inhibitors in cancer treatment and prevention.
    Vanchieri C
    J Natl Cancer Inst; 2005 Apr; 97(8):552-3. PubMed ID: 15840872
    [No Abstract]   [Full Text] [Related]  

  • 9. Update on cancer-preventive therapeutics.
    Brenner DE
    Clin Adv Hematol Oncol; 2004 Jan; 2(1):25-6, 64. PubMed ID: 16163155
    [No Abstract]   [Full Text] [Related]  

  • 10. Hormonal interventions to prevent hormonal cancers: breast and prostate cancers.
    Dunn BK; Ford LG
    Eur J Cancer Prev; 2007 Jun; 16(3):232-42. PubMed ID: 17415094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tamoxifen or raloxifene in postmenopausal women for prevention of breast cancer: a tale of two choices--counterpoint.
    Fabian C
    Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2210-2. PubMed ID: 18006909
    [No Abstract]   [Full Text] [Related]  

  • 12. Chemoprevention clinical trials: it is time to turn success into progress.
    Brown PH
    Cancer Epidemiol Biomarkers Prev; 2007 Aug; 16(8):1531-2. PubMed ID: 17684123
    [No Abstract]   [Full Text] [Related]  

  • 13. Budget impact analysis of chemoprevention of breast cancer with tamoxifen and raloxifene among high-risk women in Japan.
    Kondo M; Hoshi SL; Toi M
    Jpn J Clin Oncol; 2009 Nov; 39(11):767-70. PubMed ID: 19656807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronicles in drug discovery.
    Moral MA; Khurdayan VK; Bozzo J
    Drug News Perspect; 2006 Oct; 19(8):485-9. PubMed ID: 17160149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Non-steroidal anti-inflammatory agents and prevention of colorectal adenomas and carcinomas].
    Raskov HH
    Ugeskr Laeger; 2006 Jan; 168(4):359-62. PubMed ID: 16436235
    [No Abstract]   [Full Text] [Related]  

  • 16. Chemoprevention of breast cancer.
    Castrellon AB; Glück S
    Expert Rev Anticancer Ther; 2008 Mar; 8(3):443-52. PubMed ID: 18366291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vioxx withdrawal alarms cancer prevention researchers.
    Vanchieri C
    J Natl Cancer Inst; 2004 Dec; 96(23):1734-5. PubMed ID: 15572751
    [No Abstract]   [Full Text] [Related]  

  • 18. Chemoprevention of colorectal carcinogenesis.
    Umar A; Viner JL; Richmond E; Anderson WF; Hawk ET
    Int J Clin Oncol; 2002 Feb; 7(1):2-26. PubMed ID: 11942045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reducing the "risk" of chemoprevention: defining and targeting high risk--2005 AACR Cancer Research and Prevention Foundation Award Lecture.
    Lippman SM; Lee JJ
    Cancer Res; 2006 Mar; 66(6):2893-903. PubMed ID: 16540634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tamoxifen prevention claim will not be allowed in USA.
    Ault A
    Lancet; 1998 Sep; 352(9131):883. PubMed ID: 9742990
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.